Inhibition of experimental angiogenesis by the somatostatin analogue octreotide acetate (SMS 201-995)

Clinical Cancer Research

Volumn 3, Issue 2, 1997, Pages 265-272

  Danesi, Romano ^a,b   Agen, Cristiana ^b   Benelli, Umberto ^b   Di Paolo, Antonello ^a   Nardini, Denise ^b   Bocci, Guido ^b   Basolo, Fulvio ^b   Campagni, Antonio ^c   Del Tacca, Mario ^b  

^a SCUOLA SUPERIORE SANT ANNA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c Ctro Interforze Studie A   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CHORIOALLANTOIS; CONTROLLED STUDY; CORNEA; HUMAN; HUMAN CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PREVENTION; PRIORITY JOURNAL; RAT;

ANIMALS; AORTA; CELL DIVISION; CELLS, CULTURED; CHICK EMBRYO; CHICKENS; CORNEA; CULTURE MEDIA, CONDITIONED; DRUG INTERACTIONS; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; FIBRIN; FIBRONECTINS; HUMANS; MESENTERY; NEOVASCULARIZATION, PATHOLOGIC; OCTREOTIDE; P-METHOXY-N-METHYLPHENETHYLAMINE; RATS; RATS, WISTAR; SOMATOSTATIN; TUMOR CELLS, CULTURED;

EID: 0031019186     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Reubi, J-C., and Laissue, J. A. Multiple actions of somatostatin in neoplastic disease. Trends Pharmacol. Sci., 16: 110-115, 1995.
2. Bauer, W., Briner, U., and Doepfner, W. SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action. Life Sci., 31: 1131-1140, 1982.
3. Lamberts, S. W., van der Lely, A-J., de Herder, W. W., and Hofland, L. J. Octreotide. N. Engl. J. Med., 334: 246-254, 1996.
4. Weckbecker, G., Liu, R., Tolcsvai, L., and Bruns, C. Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro. Cancer Res., 52: 4973-4978, 1992.
5. Ruszniewski, P., Lehy, T., Reyl-Desmars, F., Le Roux, S., and Lewin, M. J. Octreotide (SMS 201-995) inhibits the growth of colon peritoneal carcinomatosis in BDIX rats. Regul. Pept., 43: 141-147, 1993.
6. Di Paolo, A., Bocci, G., Innocenti, F., Agen, C., Nardini, D., Danesi, R., and Del Tacca, M. Inhibitory effect of the somatostatin analogue SMS 201-995 and cytokines on the proliferation of human colon adenocarcinoma cell lines. Pharmacol. Res., 32: 135-139, 1995.
7. Bensaid, M., Tahiri-Jouti, N., Cambillau, C., and Viguerie, N. Basic fibroblast growth factor induces proliferation of a rat pancreatic cancer cell line: inhibition by somatostatin. Int. J. Cancer. 50: 796-804, 1992.
8. Nillson, O., Wangberg, B., Theodorsson, E., Skottner, A., and Ahlman, H. Presence of IGF-I in human midgut carcinoid tumors: an autocrine regulator of carcinoid tumor growth? Int. J. Cancer, 51: 195-203, 1992.
9. Ezzat, S., Ren, S. G., and Braunstein, G. D. Octreotide stimulates insulin-like growth factor binding protein-I (IGFBP-I) levels in acromegaly. J. Clin. Endocrinol. Metab., 73: 441-443, 1991.
10. Liebow, C., Reilly, C., Serrano, M., and Schally, A. V. Somatostatin analogues inhibit growth of pancreatic cancer by stimulating tyrosine phosphatase. Proc. Natl. Acad. Sci. USA. 86: 2003-2007, 1989.
11. Bobik, A., and Campbell, J. H. Vascular derived growth factors: cell biology, pathophysiology, and pharmacology. Pharmacol. Rev., 45: 1-42, 1993.
12. Woltering, E. A., Barrie, R., O'Dorisio, T. M., Arce, D., Ure, T., Cramer, A., Holmes, D., Robertson, J., and Fassler, J. Somatostatin analogues inhibit angiogenesis in the chick chorioallantoic membrane. J. Surg. Res., 50: 245-251, 1991.
13. Barrie, R., Woltering, E. A., Hajarizadeh, H., Mueller, C., Ure, T., and Fletcher, W. S. Inhibition of angiogenesis by somatostatin and somatostatin-like compounds is structurally dependent. J. Surg, Res., 55: 446-450, 1993.
14. Mallet, B., Vialettes, B., Haroche, S., Escoffier, P., Gastaut, P., Taubert, J-P., and Vague, P. Stabilization of severe proliferative diabetic retinopathy by long-term treatment with SMS 201-995. Diabete Metabol., 18: 438-444, 1992.
15. Danesi, R., Del Bianchi, S., Soldani, P., Campagni, A., La Rocca, R. V., Myers, C. E., Paparelli, A., and Del Tacca, M. Suramin inhibits bFGF-induced endothelial cell proliferation and angiogenesis in the chick chorioallantoic membrane. Br. J. Cancer, 68: 932-938, 1993.
16. Costa, M., Danesi, R., Agen, C., Di Paolo, A., Basolo, F., Del Bianchi, S., and Del Tacca, M. MCF-10A cells infected with the int-2 oncogene induce angiogenesis in the chick chorioallantoic membrane and in the rat mesentery. Cancer Res., 54: 9-11, 1994.
17. Plunkett, M. L., and Hailey, J. A. An in vivo quantitative angiogenesis model using tumor cells entrapped in alginate. Lab. Invest., 62: 510-517, 1990.
18. Diglio, C. A., Grammas, P., Giacomelli, F., and Wiener, J. Angiogenesis in rat aorta ring explant cultures. Lab. Invest., 60: 523-531, 1989.
19. Wesseling, P., van der Laak, J. A. W. M., de Leeuw, H., Ruiter, D. J., and Burger, P. C. Quantitative immunohistological analysis of the microvasculature in untreated human glioblastoma multiforme. J. Neurosurg., 81: 902-909, 1994.
20. Nicosia, R. F., and Ottinetti, A. Growth of microvessels in serum-free matrix culture of rat aorta: a quantitative assay of angiogenesis in vitro. Lab. Invest., 63: 115-122, 1990.
21. Proia, A. D., Chandler, D. B., Haynes, W. L., Smith, C. F., Suvarnamani, C., Erkel, F. H., and Klintworth, G. K. Quantitation of corneal vascularization using computerized image analysis. Lab. Invest., 58: 473-479, 1989.
22. Lepri, A., Benelli, U., Bernardini, N., Bianchi, F., Lupetti, M., Danesi, R., Del Tacca, M., and Nardi, M. Effect of low molecular weight heparan sulfate on angiogenesis in the rat cornea after chemical cauterization. J. Ocul. Pharmacol. Ther., 10: 273-280, 1994.
23. Norrby, K., Jakobsson, A., and Sorbo, J. Quantitative angiogenesis in spreads of intact rat mesenteric windows. Microvasc. Res., 39: 341-348, 1990.
24. Cockerill, G. W., Gamble, J. R., and Vadas, M. A. Angiogenesis: models and modulators. Int. Rev. Cytol., 159: 113-160, 1995.
25. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-31, 1995.
26. Battegay, E. J. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J. Mol. Med., 73: 333-346, 1995.
27. Folkman, J. Clinical applications of research on angiogenesis. N. Engl. J. Med., 333: 1757-1763, 1995.
28. Patel, P. C., Barrie, R., Hill, N., Landeck, S., Kurozawa, D., and Woltering, E. A. Postreceptor signal transduction mechanisms involved in octreotide-induced inhibition of angiogenesis. Surgery. 116: 1148-1152, 1994.
29. Hofland, L. H., Visser-Wisselaar, H. A., and Lamberts, S. W. J. Somatostatin analogs: clinical application in relation to human somatostatin receptor subtypes. Biochem. Pharmacol., 50: 287-297, 1995.
30. Grant, M. B., Caballero, S., and Millard, W. J. Inhibition of IGF-I and b-FGF stimulated growth of human retinal endothelial cells by the somatostatin analogue, octreotide: a potential treatment for ocular neo-vascularization. Regul. Pept., 48: 267-278, 1993.
31. Modlin, I. M., Kumar, R., Nangia, A., and Soroka, C. J. Gastrin-dependent inhibitory effects of octreotide on the genesis of gastric ECLomas. Surgery, 112: 1048-1056, 1992.
32. Weckbecker, G., Tolcsvai, L., Stolz, B., Pollak, M., and Bruns, C. Somatostatin analogue octreotide enhances the antineoplastic effects of tamoxifen and ovariectomy on 7,12-dimethylbenz[a]anthracene-induced rat mammary carcinomas. Cancer Res., 54: 6334-6337, 1994.